Abstract
Background: Although the anticancer activity of Korean Red Ginseng (KRG) has been known in various cancers, the mechanism of KRG-induced apoptosis is unknown in colorectal cancer (CRC). In our study, we examined whether KRG induces apoptosis in CRC cells. Methods: In the cell viability assay, the concentration of the appropriate KRG extracts was fixed at 2.5 mg/mL in numerous CRC cells. This fixed concentration was in other experiments, and it was confirmed that the KRG extracts induce apoptosis in CRC cells. Results: We found that KRG induced Noxa activation and apoptosis and increased endoplasmic reticulum stress via reactive oxygen species production. This indicated that KRG efficiently enhanced cell death in CRC cells. Conclusion: Our results show that KRG can be used as a possible anticancer drug for patients with CRC.
Author supplied keywords
Cite
CITATION STYLE
Jeong, Y. A., Kim, B. R., Kim, D. Y., Jeong, S., Na, Y. J., Kim, J. L., … Oh, S. C. (2019). Korean red ginseng extract increases apoptosis by activation of the noxa pathway in colorectal cancer. Nutrients, 11(9). https://doi.org/10.3390/nu11092026
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.